Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back...

|About: Catalyst Pharmaceutical Par... (CPRX)|By:, SA News Editor

Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back of its earlier announcement that the independent Data Monitoring Committee overseeing CPRX's Phase III clinical trials of Firdapse, a potential treatment for Lambert-Easton Myasthenic Syndrome, gave the go-ahead to continue the trial as planned based on a review of safety and clinical data.